Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases

Clinical trial NCT07184450 · RECRUITING

Trial details

NCT number: NCT07184450
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Juvenile Dermatomyositis (JDM)Polyarticular Juvenile Idiopathic Arthritis Systemic Sclerosis (SSc)Primary Sjogren's Syndrome

Start date: 2025-09-01
Primary completion: 2026-03-30
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.